Importer of Controlled Substances; Notice of Registration; Cerilliant Corporation, 1389-1390 [2014-00057]
Download as PDF
<![CDATA[
1389
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 5 / Wednesday, January 8, 2014 / Notices
reach a preliminary determination in
antidumping and countervailing duty
investigations in 45 days, or in this case
by February 14, 2014. The
Commission’s views must be
transmitted to Commerce within five
business days thereafter, or by February
24, 2014.
DATES: Effective December 31, 2013.
FOR FURTHER INFORMATION CONTACT:
Chris Cassise (202–708–5408), Office of
Investigations, U.S. International Trade
Commission, 500 E Street SW.,
Washington, DC 20436. Hearingimpaired persons can obtain
information on this matter by contacting
the Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server (https://
www.usitc.gov). The public record for
these investigations may be viewed on
the Commission’s electronic docket
(EDIS) at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION: For
further information concerning the
conduct of these investigations and
rules of general application, consult the
Commission’s Rules of Practice and
Procedure, part 201, subparts A through
E (19 CFR part 201), and part 207,
subparts A and B (19 CFR part 207).
Background.—These investigations
are being instituted in response to a
petition filed on December 31, 2013, by
SolarWorld America Industries, Inc.,
Hillsboro, OR.
Participation in the investigations and
public service list.—Persons (other than
petitioners) wishing to participate in the
investigations as parties must file an
entry of appearance with the Secretary
to the Commission, as provided in
sections 201.11 and 207.10 of the
Commission’s rules, not later than seven
days after publication of this notice in
the Federal Register. Industrial users
and (if the merchandise under
investigation is sold at the retail level)
representative consumer organizations
have the right to appear as parties in
Commission antidumping and
countervailing duty investigations. The
Secretary will prepare a public service
list containing the names and addresses
of all persons, or their representatives,
who are parties to these investigations
upon the expiration of the period for
filing entries of appearance.
Limited disclosure of business
proprietary information (BPI) under an
administrative protective order (APO)
and BPI service list.—Pursuant to
VerDate Mar<15>2010
18:42 Jan 07, 2014
Jkt 232001
section 207.7(a) of the Commission’s
rules, the Secretary will make BPI
gathered in these investigations
available to authorized applicants
representing interested parties (as
defined in 19 U.S.C. 1677(9)) who are
parties to the investigations under the
APO issued in the investigations,
provided that the application is made
not later than seven days after the
publication of this notice in the Federal
Register. A separate service list will be
maintained by the Secretary for those
parties authorized to receive BPI under
the APO.
Conference.—The Commission’s
Director of Investigations has scheduled
a conference in connection with these
investigations for 9:30 a.m. on January
21, 2014, at the U.S. International Trade
Commission Building, 500 E Street SW.,
Washington, DC. Requests to appear at
the conference should be emailed to
William.bishop@usitc.gov and
Sharon.bellamy@usitc.gov (DO NOT
FILE ON EDIS) on or before January 16,
2014. Parties in support of the
imposition of countervailing and
antidumping duties in these
investigations and parties in opposition
to the imposition of such duties will
each be collectively allocated one hour
within which to make an oral
presentation at the conference. A
nonparty who has testimony that may
aid the Commission’s deliberations may
request permission to present a short
statement at the conference.
Written submissions.—As provided in
sections 201.8 and 207.15 of the
Commission’s rules, any person may
submit to the Commission on or before
January 24, 2014, a written brief
containing information and arguments
pertinent to the subject matter of the
investigations. Parties may file written
testimony in connection with their
presentation at the conference no later
than three days before the conference. If
briefs or written testimony contain BPI,
they must conform with the
requirements of sections 201.6, 207.3,
and 207.7 of the Commission’s rules.
Please consult the Commission’s rules,
as amended, 76 FR 61937 (Oct. 6, 2011)
and the Commission’s Handbook on
Filing Procedures, 76 FR 62092 (Oct. 6,
2011), available on the Commission’s
Web site at https://edis.usitc.gov.
In accordance with sections 201.16(c)
and 207.3 of the rules, each document
filed by a party to the investigations
must be served on all other parties to
the investigations (as identified by
either the public or BPI service list), and
a certificate of service must be timely
filed. The Secretary will not accept a
document for filing without a certificate
of service.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Authority: These investigations are being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.12 of the
Commission’s rules.
Issued: January 3, 2014.
By order of the Commission.
William R. Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2014–00130 Filed 1–7–14; 8:45 am]
BILLING CODE 7020–02–P
JUDICIAL CONFERENCE OF THE
UNITED STATES
Hearings of the Judicial Conference
Advisory Committee on Rules of
Bankruptcy Procedure; Federal
Register Citation of Previous
Announcement: 78 FR 49768.
Judicial Conference of the
United States, Advisory Committee on
Rules of Bankruptcy Procedure.
ACTION: Notice of Cancellation of Open
Hearing.
AGENCY:
The following public hearing
on proposed amendments to the Federal
Rules of Bankruptcy Procedure has been
canceled: Bankruptcy Rules Hearing,
January 31, 2014, Washington, DC
FOR FURTHER INFORMATION CONTACT:
Jonathan C. Rose, Secretary and Chief
Rules Officer, Rules Committee Support
Office, Administrative Office of the
United States Courts, Washington, DC
20544, telephone (202) 502–1820.
SUMMARY:
Dated: January 3, 2014.
Jonathan C. Rose,
Secretary and Chief Rules Officer.
[FR Doc. 2014–00112 Filed 1–7–14; 8:45 am]
BILLING CODE 2210–55–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Cerilliant
Corporation
By Notice dated September 9, 2013,
and published in the Federal Register
on September 17, 2013, 78 FR 57176,
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
Cathinone (1235) ..........................
E:\FR\FM\08JAN1.SGM
08JAN1
Schedule
I
1390
Federal Register / Vol. 79, No. 5 / Wednesday, January 8, 2014 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
Drug
Schedule
Methcathinone (1237) ..................
Mephedrone (1248) ......................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
Fenethylline (1503) .......................
Gamma
Hydroxybutyric
Acid
(2010).
JWH-018 (7118) ...........................
JWH-073 (7173) ...........................
JWH-200 (7200) ...........................
Alpha-ethyltryptamine (7249) .......
Ibogaine (7260) ............................
CP-47497 (7297) ..........................
CP-47497 C8 Homologue (7298)
Lysergic acid diethylamide (7315)
2C-T-7 (7348) ...............................
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
3,4,5-Trimethoxyamphetamine
(7390).
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
5-Methoxy-N-Ndimethyltryptamine (7431).
Alpha-methyltryptamine (7432) ....
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
5-Methoxy-N,Ndiisopropyltryptamine (7439).
N-Benzylpiperazine (7493) ...........
MDPV (7535) ................................
Methylone (7540) .........................
Desomorphine (9055) ...................
Etorphine (except HCl)(9056) ......
Heroin (9200) ...............................
Morphine-N-oxide (9307) .............
Normorphine (9313) .....................
Pholcodine (9314) ........................
Dextromoramide (9613) ...............
Dipipanone (9622) ........................
Racemoramide (9645) ..................
Trimeperidine (9646) ....................
1-Methyl-4-phenyl-4propionoxypiperidine (9661).
Tilidine (9750) ...............................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
VerDate Mar<15>2010
16:42 Jan 07, 2014
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
Jkt 232001
Schedule
Drug
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (9273)
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Poppy Straw Concentrate (9670)
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
DEPARTMENT OF JUSTICE
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Drug Enforcement Administration
The company plans to import small
quantities of the listed controlled
substances for the manufacture of
analytical reference standards.
In reference to drug codes 7360 and
7370, the company plans to import a
synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other
activities for these drug codes are
authorized for this registration.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR
3417(2007)
DEA has considered the factors in 21
U.S.C. 823(a) and 952(a) and determined
that the registration of Cerilliant
Corporation to import the basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. DEA has
investigated Cerilliant Corporation to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: December 23, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Manufacturer of Controlled
Substances; Notice of Application;
Noramco, Inc. (GA)
Pursuant to 21 CFR 1301.33(a), this is
notice that on July 4, 2013, Noramco,
Inc., 1440 Olympic Drive, Athens,
Georgia 30601, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Drug
Gamma
Hydroxybutyric
Acid
(2010).
Dihydromorphine (9145) ...............
Morphine-N-oxide (9307) .............
Codeine-N-oxide (9053) ...............
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Opium tincture (9630) ..................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Carfentanil (9743) .........................
Tapentadol (9780) ........................
Fentanyl (9801) ............................
Schedule
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substance,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administrator, Office of Diversion
Control, Federal Register Representative
(ODW), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than March 10, 2014.
[FR Doc. 2014–00057 Filed 1–7–14; 8:45 am]
Dated: December 23, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
BILLING CODE 4410–09–P
[FR Doc. 2014–00054 Filed 1–7–14; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00029
Fmt 4703
Sfmt 9990
E:\FR\FM\08JAN1.SGM
08JAN1
]]>Agencies
[Federal Register Volume 79, Number 5 (Wednesday, January 8, 2014)]
[Notices]
[Pages 1389-1390]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-00057]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration;
Cerilliant Corporation
By Notice dated September 9, 2013, and published in the Federal
Register on September 17, 2013, 78 FR 57176, Cerilliant Corporation,
811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as an importer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
[[Page 1390]]
Methcathinone (1237)....................... I
Mephedrone (1248).......................... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
Fenethylline (1503)........................ I
Gamma Hydroxybutyric Acid (2010)........... I
JWH-018 (7118)............................. I
JWH-073 (7173)............................. I
JWH-200 (7200)............................. I
Alpha-ethyltryptamine (7249)............... I
Ibogaine (7260)............................ I
CP-47497 (7297)............................ I
CP-47497 C8 Homologue (7298)............... I
Lysergic acid diethylamide (7315).......... I
2C-T-7 (7348).............................. I
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
3,4,5-Trimethoxyamphetamine (7390)......... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
3,4-Methylenedioxyamphetamine (7400)....... I
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
4-Methoxyamphetamine (7411)................ I
5-Methoxy-N-N-dimethyltryptamine (7431).... I
Alpha-methyltryptamine (7432).............. I
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
5-Methoxy-N,N-diisopropyltryptamine (7439). I
N-Benzylpiperazine (7493).................. I
MDPV (7535)................................ I
Methylone (7540)........................... I
Desomorphine (9055)........................ I
Etorphine (except HCl)(9056)............... I
Heroin (9200).............................. I
Morphine-N-oxide (9307).................... I
Normorphine (9313)......................... I
Pholcodine (9314).......................... I
Dextromoramide (9613)...................... I
Dipipanone (9622).......................... I
Racemoramide (9645)........................ I
Trimeperidine (9646)....................... I
1-Methyl-4-phenyl-4-propionoxypiperidine I
(9661).
Tilidine (9750)............................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Ecgonine (9180)............................ II
Ethylmorphine (9190)....................... II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Dextropropoxyphene, bulk (9273)............ II
Morphine (9300)............................ II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Levo-alphacetylmethadol (9648)............. II
Oxymorphone (9652)......................... II
Poppy Straw Concentrate (9670)............. II
Alfentanil (9737).......................... II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances for the manufacture of analytical reference
standards.
In reference to drug codes 7360 and 7370, the company plans to
import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No
other activities for these drug codes are authorized for this
registration.
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417(2007)
DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and
determined that the registration of Cerilliant Corporation to import
the basic classes of controlled substances is consistent with the
public interest and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971. DEA has
investigated Cerilliant Corporation to ensure that the company's
registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems, verification of the company's compliance with state and local
laws, and a review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR
1301.34, the above named company is granted registration as an importer
of the basic classes of controlled substances listed.
Dated: December 23, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2014-00057 Filed 1-7-14; 8:45 am]
BILLING CODE 4410-09-P
